Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
Apple
AAPL
5
Gorilla Technology
GRRR
US Stock MarketDetailed Quotes
GEMP Gemphire Therapeutics
- 0.000
- 0.0000.00%
Close Mar 11 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)18.97MShares8.50052wk High0.00P/B0Float Cap7.25052wk Low--Dividend TTM9.01MShs Float539.750Historical High--Div YieldTTM0.00%Amplitude5.950Historical Low--Avg Price1Lot Size
Gemphire Therapeutics News
Gemphire Therapeutics | 8-K: Current report
Gemphire Therapeutics | 8-K: Current report
Gemphire Therapeutics | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)
Gemphire Therapeutics | S-8 POS: S-8 POS
Gemphire Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Gemphire Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Gemphire Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Gemphire Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Gemphire Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Gemphire Therapeutics | NT 20-F: Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F
Gemphire Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Gemphire Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Gemphire Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Gemphire Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
No More